|
Condensed Consolidated Statements of Income (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified
|
3 Months Ended |
|
Mar. 31, 2015
|
Mar. 31, 2014
|
| Income Statement [Abstract] |
|
|
| Net revenue |
$ 639,395 |
$ 566,338 |
| Operating expenses: |
|
|
| Practice salaries and benefits |
419,595 |
372,040 |
| Practice supplies and other operating expenses |
23,431 |
21,417 |
| General and administrative expenses |
67,936 |
58,414 |
| Depreciation and amortization |
13,612 |
10,370 |
| Total operating expenses |
524,574 |
462,241 |
| Income from operations |
114,821 |
104,097 |
| Investment income |
142 |
1,635 |
| Interest expense |
(3,267) |
(1,371) |
| Equity in earnings of unconsolidated affiliate |
821 |
|
| Total non-operating (expenses) income |
(2,304) |
264 |
| Income before income taxes |
112,517 |
104,361 |
| Income tax provision |
43,928 |
40,701 |
| Net income |
68,589 |
63,660 |
| Net loss attributable to noncontrolling interests |
118 |
|
| Net income attributable to MEDNAX, Inc. |
$ 68,707 |
$ 63,660 |
| Net income attributable to MEDNAX, Inc.: |
|
|
| Earnings per share, Basic |
$ 0.73 |
$ 0.64 |
| Earnings per share, Diluted |
$ 0.72 |
$ 0.63 |
| Weighted average common shares: |
|
|
| Basic |
94,231 |
99,076 |
| Diluted |
95,325 |
100,696 |